• LAST PRICE
    0.2675
  • TODAY'S CHANGE (%)
    Trending Up0.0105 (4.0856%)
  • Bid / Lots
    0.2668/ 31
  • Ask / Lots
    0.2700/ 1
  • Open / Previous Close
    0.2570 / 0.2570
  • Day Range
    Low 0.2500
    High 0.2800
  • 52 Week Range
    Low 0.2208
    High 2.2700
  • Volume
    345,408
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 0.257
TimeVolumePTPI
09:32 ET67790.257
09:33 ET2000.25
09:37 ET28520.252
09:39 ET6000.25
09:42 ET30260.2569
09:44 ET20000.2569
09:46 ET38940.2569
09:48 ET104300.257
09:50 ET1000.2598
09:51 ET1000.2599
09:53 ET12500.2599
09:55 ET10000.2598
09:57 ET30000.2599
10:00 ET224180.263
10:02 ET25000.263151
10:04 ET49000.2665
10:06 ET261560.2664
10:08 ET261690.275001
10:09 ET58000.2775
10:11 ET59000.2799
10:13 ET6410.2799
10:15 ET171180.28
10:18 ET459220.276866
10:20 ET11000.2799
10:22 ET32790.27995
10:24 ET9960.2768
10:26 ET1000.2799
10:38 ET105000.27
10:40 ET1000.2748
10:45 ET2000.274899
10:49 ET26850.27
10:51 ET10000.269901
10:54 ET12500.27
11:00 ET125310.27
11:02 ET76880.269
11:03 ET1500.269
11:05 ET10000.2695
11:07 ET30000.27
11:09 ET61760.26999
11:12 ET20000.27
11:14 ET69600.27
11:16 ET31000.2699
11:18 ET21000.2699
11:20 ET19980.2699
11:21 ET9990.269499
11:25 ET1000.27
11:30 ET276480.2674
11:43 ET1000.269
11:50 ET8000.2689
11:52 ET22000.268
11:56 ET10000.2681
11:57 ET10000.2689
11:59 ET28000.26845
12:01 ET10000.2689
12:10 ET3920.26845
12:30 ET1000.269
12:42 ET201520.269
12:46 ET16000.269
12:57 ET28380.2668
01:08 ET2010.2675
01:09 ET1000.2699
01:15 ET184950.2675
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesPTPI
Petros Pharmaceuticals Inc
2.6M
-0.1x
---
United StatesSTMM
Stemcell Holdings Inc
1.6M
750.0x
---
United StatesKANT
Kineta Inc
5.5M
-0.3x
---
United StatesATHXQ
Athersys Inc
60.0
0.0x
---
United StatesGBIM
Globeimmune Inc
10.0
0.0x
---
United StatesEVGN
Evogene Ltd
8.1M
-0.4x
---
As of 2024-11-22

Company Information

Petros Pharmaceuticals, Inc. is a pharmaceutical company focused on expanding consumer access to medication through over-the-counter (OTC) drug development programs. The Company is pursuing access to its flagship prescription erectile dysfunction (ED) therapy, Stendra, via potential OTC designation. Stendra is a Phosphodiesterase - 5 (PDE - 5) inhibitor prescription medication for the treatment of ED and is the only patent protected PDE-5 inhibitor on the market. Stendra offers the ED therapeutic landscape a valuable addition as an oral ED therapy that may be taken once daily as early as approximately 15 minutes prior to sexual engagement, with or without food, when using the 100mg or 200mg dosing, subject to certain contraindications and limitations common among PDE-5 inhibitors. It also markets its own line of medical devices intended for ED treatment through its subsidiaries, Timm Medical and PTV, including the VED systems marketed as Osbon ErecAid and PosTVac.

Contact Information

Headquarters
1185 Avenue Of The Americas 3Rd Floor, Suite 570NEW YORK, NY, United States 10036
Phone
973-242-0005
Fax
302-655-5049

Executives

Independent Non-Executive Chairman of the Board
Joshua Silverman
President, Chief Commercial Officer
Fady Boctor
Chief Accounting Officer, Vice President - Finance
Mitchell Arnold
Independent Director
Bruce Bernstein
Independent Director
Wayne Walker

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$2.6M
Revenue (TTM)
$4.0M
Shares Outstanding
10.0M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
2.17
EPS
$-4.22
Book Value
$4.17
P/E Ratio
-0.1x
Price/Sales (TTM)
0.6
Price/Cash Flow (TTM)
---
Operating Margin
-337.80%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.